CA3155646A1 — Gel base composition for compounding into a mucoadhesive delivery system
Assigned to Medisca Pharmaceutique Inc · Expires 2021-04-01 · 5y expired
What this patent protects
The present invention relates to concentrated mucoadhesive base compositions having a high viscosity of at least 50,000 cPs, which can be processed upon dilution into a gel dosage form and upon drying into a strip dosage form for use as a carrier for the administration of active …
USPTO Abstract
The present invention relates to concentrated mucoadhesive base compositions having a high viscosity of at least 50,000 cPs, which can be processed upon dilution into a gel dosage form and upon drying into a strip dosage form for use as a carrier for the administration of active ingredients to mucocutaneous surfaces, such as the oral, rectal, nasal or vaginal cavities.
Drugs covered by this patent
- Renacidin (CITRIC ACID) · Baxter
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.